跳至主要内容
临床试验/KCT0006199
KCT0006199招募中未知

Glycosylated hemoglobin is a predictive factor for response of radical radiotherapy in patients with stage 3 non-small cell lung cancer

Kyung Hee University Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • Histologically confirmed primary lung cancer
  • - From January 2010 to December 2019, the patients received radical radiotherapy in Kyung University Medical Center for management of lung cancer
  • - AJCC stage 3 lung cancer
  • - ECOG performance status 0, 1, or 2
  • - Follow-up period =1 year after completion of radiotherapy
  • - The patients who were checked hemoglobin A1c 2 week before the start of radiotherapy

排除标准

  • - Histologically confirmed small cell lung cancer
  • - Receipt of a total radiotherapy dose =50 Gy
  • - No available imaging studies for evaluation of cancer recurrence

研究者

发起方
Kyung Hee University Hospital

相似试验